Table 1 Patient characteristics
Responded study questionnaires | p value | ||
|---|---|---|---|
Yes | No | ||
(n = 77) | (n = 15) | ||
Gender (males) | 55.8% | 66.7% | 0.44 |
Late onset (≥50 years) | 39.0% | 26.7% | 0.37 |
TTR V30M mutation | 98.7% | 93.3% | 0.19 |
Age at onset (years) | 47.3 (24.1-66.0) | 39.5 (22.1-65.5) | 0.07 |
Age at LTx (years) | 50.1 (29.6-69.2) | 42.4 (25.2-67.9) | 0.08 |
Disease duration at LTx (years) | 3.3 (0.5-12.1) | 3.1 (1.9-9.0) | 0.61 |
T50 pre LTx (min) | 118 (48–350) | 122 (56–235) | 0.81 |
Total GI symptom score pre LTx | 7 (0–35) | 5.5 (0–21) | 0.39 |
mBMI pre LTx | 993 (550–1447) | 973 (796–1320) | 0.67 |
Age at study start (years) | 58.9 (35.1-75.6) | 53.3 (41.7-75.5) | 0.12 |